This study looks at whether older adults (60+) living with HIV in Kenya can safely switch from their current three-drug pill to a simpler two-drug pill called DTG/3TC. About 240 participants who are already stable on treatment will be followed for 96 weeks. The main goal is to se…
Phase: PHASE3 • Sponsor: University of Nairobi • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC